Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene

Summary

Phase III Study to Demonstrate the non inferiority of PLURAIR® branded nasal topical Fluticasone Propionate (FP) in relation to the FLIXONASE® brand reference drug in the control of nasal symptoms related to perennial allergic rhinitis.

Timeline

Start

2014-07-04

Primary completion

2020-04-01

Completion

2020-04-01

Drugs

Indications